Accelerated Integration of Scarce Medical Service Resources in China's First-Tier Cities
BioMérieux accelerates the development of molecular diagnostics business in China.
Committed to becoming the world's largest production base of culture media and an international leading CDMO platform.
Possesses the core advantages of "brand + technology + internationalization + fashion."
This round of financing will be used to further accelerate key industrial layout and build an AI-based enterprise ecosystem.
Synthetic Bio
Research on the Sweetener Industry
Healthcare
2023 CEC Capital China Healthcare Industry White Paper Core Perspectives
Synthetic Bio
Biomanufacturing and Microbial ...